Hydrophilic Coating for Subcutaneous Vascular Access Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The placement of vascular access systems is prone to complications such as trauma, infection, biofilm formation, and thrombosis due to skin stretching, scar tissue formation, and the introduction of pathogens during the procedure.

Innovation Solution

A subcutaneous vascular access system featuring a coating on its surface that transitions from a deactivated to an activated state upon immersion in a solution, providing lubricity for easier insertion and acting as a reservoir for active ingredients such as antibiotics to prevent infection and biofilm formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a vascular access system is placed subcutaneously, then vascular access is achieved, but trauma, skin stretching, and scar tissue formation occur during tissue pocket formation and catheter placement

Engineering Contradiction:
Improvevascular access achievementVSAvoidtrauma and skin stretching
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The coating is applied to the catheter and port components before the vascular access procedure. This preliminary application ensures that the lubricious and active ingredients are already in place on the surfaces that will contact tissue during insertion and placement, preventing trauma and reducing skin stretching before the harmful effects can occur.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The coating acts as an intermediary layer between the vascular access system components and the surrounding tissue. This intermediate layer provides lubrication to reduce mechanical trauma during insertion and serves as a reservoir for active ingredients that protect the tissue from harmful effects during the procedure.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If a vascular access system is placed subcutaneously, then access is established, but pathogens are introduced leading to post-placement infections

Engineering Contradiction:
Improvevascular access establishmentVSAvoidpathogen introduction and infection
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The coating with active ingredients is applied to the vascular access system components before the procedure. This preliminary action ensures that antimicrobial and anti-infective agents are already present on the surfaces that will contact tissue and blood during insertion and placement, preventing pathogen introduction before infections can occur.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The active ingredients in the coating provide preliminary anti-infective action by being present on the device surfaces before the procedure begins. This preemptive measure counteracts the potential introduction of pathogens during the placement procedure, preventing infections rather than treating them after they occur.

Inventive Principle:
Principle #9Preliminary anti-action

3Reliability

If a foreign body is placed subcutaneously, then vascular access is provided, but biofilm formation occurs on the implanted device

Engineering Contradiction:
Improvevascular access provisionVSAvoidbiofilm formation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The coating with active ingredients is applied to the vascular access system components before implantation. This preliminary action ensures that anti-biofilm agents are already present on the device surfaces that will be implanted subcutaneously, preventing biofilm formation from the outset rather than allowing it to develop after placement.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The active ingredients in the coating provide preliminary anti-biofilm action by being present on the device surfaces before they come into contact with bodily fluids and bacteria. This preemptive measure counteracts the natural tendency of foreign bodies to generate biofilm, preventing the harmful effect before it can occur.

Inventive Principle:
Principle #9Preliminary anti-action

4Reliability

If a foreign body is placed subcutaneously, then access is established, but thrombosis formation occurs

Engineering Contradiction:
Improveaccess establishmentVSAvoidthrombosis formation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The coating with active ingredients is applied to the vascular access system components before the procedure. This preliminary action ensures that anti-thrombotic agents are already present on the catheter and port surfaces that will contact blood during insertion and placement, preventing thrombosis formation from the beginning.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The active ingredients in the coating provide preliminary anti-thrombotic action by being present on the device surfaces before they contact blood. This preemptive measure counteracts the tendency of foreign bodies to trigger thrombosis, preventing clot formation rather than allowing it to develop after implantation.

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The coating facilitates smoother insertion of the vascular access system, reduces the risk of infection and biofilm formation, and provides extended elution of active ingredients, thereby enhancing the safety and efficacy of the placement procedure.

Implementation Method 1

The coating can include a hydrophilic material... immersing a portion of the access port in a solution to transition the coating to an activated state

Methodology Applied
Scientific EffectHydrophilic absorption: Absorption (physical)

Implementation Method 2

absorbing an active ingredient from the solution

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Implementation Method 3

absorbing an active ingredient from the solution

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 4

eluting the active ingredient following subcutaneous implantation... eluting the active ingredient over a period of 48 hours

Methodology Applied
Scientific EffectElution: Diffusion

Implementation Method 5

The coating can include a lubricious and/or hydrophilic coating configured to reduce infection, reduce biofilm formation, and improve ease of insertion

Methodology Applied
Scientific EffectLubrication: Lubrication

Data Source

PatentUS20250152930A1Coated Subcutaneous Access Device and Associated Methods
Publication Date: 2025.05.15 BARD PERIPHERAL VASCULAR INC
  • US20250152930A1 patent drawing
  • US20250152930A1 patent drawing
  • US20250152930A1 patent drawing

AI summary

Embodiments disclosed herein are directed to a subcutaneous vascular access system including an access port, a catheter, and a cathlock, and including a coating disposed on a surface thereof. The coating can include a lubricious and or hydrophilic coating. The hydrophilic coating can be transitioned to an activated state by submersing the coating in a solution. The coating can be configured to reduce infection, reduce biofilm formation, and improve case of insertion. Embodiments include active ingredients formed within the coating and/or can be included within the solution to be loaded into the coating when activated. The active ingredients can be configured prevent infection, prevent thrombi formation, prevent biofilm formation, or combinations thereof.